Author:
Li Lei,Chen Sen,Tang Yueming,Wu Jie,He Yangzhige,Qiu Ling
Abstract
Neuroblastoma breakpoint family, member 1 (NBPF1), appears to be a double-edged sword with regard to its role in carcinogenesis. On the one hand, the tumor-suppressing functions of NBPF1 have been definitively observed in neuroblastoma, prostate cancer, cutaneous squamous cell carcinoma, and cervical cancer. On the other hand, there is evidence that NBPF1 regulates the colony formation, invasion, and maintenance of liver cancer cells and hence functions as an oncogene. The roles of NBPF1 are strictly dependent on the biological context and type of organization. However, a systematic pan-cancer analysis has thus far not been undertaken, and the significance of NBPF1 in the occurrence and progression of many malignancies is uncertain. In this paper, bioinformatics techniques were employed to analyze NBPF1 expression across different cancers and investigate the relationship between NBPF1 and clinical features, prognosis, genetic alteration, and tumor immune microenvironment, respectively. Our results show that NBPF1 is variably expressed in distinct tumor tissues and is also closely linked to clinical outcomes. In particular, compared to other tumor types, there was a strong negative correlation between NBPF1 expression and various components of the tumor microenvironment in adrenocortical carcinoma (ACC). We thus developed an NBPF1-derived immune risk model based on NBPF1-related immune genes; ACC patients with a high-risk score tended to have a poorer prognosis, accompanied by immune hyporesponsiveness. NBPF1 can be used as a prognostic biomarker for multiple cancers. Moreover, anti-NBPF1 immunotherapy may be suitable for treating ACC patients.
Subject
Endocrinology, Diabetes and Metabolism
Reference28 articles.
1. Constitutional translocation T (1,17)(P36;Q12-21) in a patient with neuroblastoma;Laureys;Genes Chromosomes Cancer,1990
2. Constitutional translocation T(1;17)(P36.31-P36.13;Q11.2-Q12.1) in a neuroblastoma patient. Establishment of somatic cell hybrids and identification of Pnd/A12m2 on chromosome 1 and Nf1/Scya7 on chromosome 17 as breakpoint flanking single copy markers;Laureys;Oncogene,1995
3. The quest for the 1p36 tumor suppressor;Bagchi;Cancer Res,2008
4. Oncomine 3.0: Genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles;Rhodes;Neoplasia,2007
5. Tumor-suppressor gene NBPF1 inhibits invasion and Pi3k/Mtor signaling in cervical cancer cells;Qin;Oncol Res,2016
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献